RPE65 and Leber congenital amaurosis: The fervor of these ongoing efforts is motivated by the recent successful treatment of the RPE65-related form of Leber congenital amaurosis (LCA), a severe blinding disease, by a recombinant adeno-associated viral (AAV) vector that corrects the genetic deficit in those patients [4].